Millennium Management’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Millennium Management’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-2,664	Closed	-$123K	–	6349
2023 Q4	$123K	Buy	+2,664	New	+$109K	﹤0.01%	5293

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

IWM

IHT Wealth Management Chicago, Illinois $4.3B AUM 21.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

SWA

Sightline Wealth Advisors Groton, Connecticut $273M AUM 18.08% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Millennium Management's GNOM Position: Q1 2024 in Review

Millennium Management sold out of Global X Genomics & Biotechnology ETF (GNOM) in Q1 2024, closing a stake of 2,664 shares — an estimated $123K sold.

Millennium Management first reported a position in GNOM in Q4 2023 and held it in 1 quarter. The position peaked at $123K in Q4 2023. 59 funds tracked by Wall St. Rank hold GNOM as of Q1 2024.

Millennium Management reported no remaining Global X Genomics & Biotechnology ETF position as of Q1 2024 after selling out during the quarter.
Millennium Management sold 2,664 Global X Genomics & Biotechnology ETF shares in Q1 2024, an estimated $123K.
Millennium Management first reported a position in Global X Genomics & Biotechnology ETF in Q4 2023 and held it in 1 quarter.
Millennium Management's Global X Genomics & Biotechnology ETF position peaked at $123K in Q4 2023.
59 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2024.

Based on Millennium Management's 13F filing for Q1 2024, filed 15 May 2024.